Substance related disorders are associated with impaired valuation of delayed gratification and feedback processing: A multilevel meta-analysis and meta-regression.

Addiction Cognition Decision-making Impulse control Impulsivity Reward impulsivity Risk-taking Substance use related disorders Temporal discounting

Journal

Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090

Informations de publication

Date de publication:
01 2020
Historique:
received: 29 01 2019
revised: 13 11 2019
accepted: 23 11 2019
pubmed: 30 11 2019
medline: 22 12 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

Across numerous studies, individuals with substance use disorders (SUDs) differed from non-using controls regarding valuation of delayed gratification and feedback processing. However, it remains unclear whether the magnitude of the effect sizes is different across these two cognitive processes and how specific SUDs as well as demographic and clinical moderators influence these effects. In this study we thus performed multilevel linear mixed-effects meta-analyses and meta-regressions to examine the effects of SUDs on the Delay Discounting Task (DD) and on the Iowa Gambling Task (IGT). We found a moderate to large effect for SUD on both, the IGT and DD. While the effect on the DD was generalized to all substance classes, a smaller effect for cannabis-related disorder when compared to other SUDs was found with regard to the IGT. Early onset of substance use and psychiatric comorbidities were associated with stronger effects on the DD. Our findings suggest that feedback processing is more vulnerable to specific substance effects, while valuation of delayed gratification depends more on developmental and clinical factors.

Identifiants

pubmed: 31778679
pii: S0149-7634(19)30072-7
doi: 10.1016/j.neubiorev.2019.11.016
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

295-307

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

B Kluwe-Schiavon (B)

Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Lenggstrasse 31, CH-8032, Zurich, Switzerland; Developmental Cognitive Neuroscience Laboratory, Brain Institute, Pontifical Catholic University of Rio Grande do Sul, Pontifical Catholic University of Rio Grande do Sul, Ipiranga Avenue, 6681, 11, 936. Partenon, 90619-900, Porto Alegre, RS, Brazil. Electronic address: brunokluwe@gmail.com.

T W Viola (TW)

Developmental Cognitive Neuroscience Laboratory, Brain Institute, Pontifical Catholic University of Rio Grande do Sul, Pontifical Catholic University of Rio Grande do Sul, Ipiranga Avenue, 6681, 11, 936. Partenon, 90619-900, Porto Alegre, RS, Brazil. Electronic address: thiago.viola@acad.pucrs.br.

B Sanvicente-Vieira (B)

Developmental Cognitive Neuroscience Laboratory, Brain Institute, Pontifical Catholic University of Rio Grande do Sul, Pontifical Catholic University of Rio Grande do Sul, Ipiranga Avenue, 6681, 11, 936. Partenon, 90619-900, Porto Alegre, RS, Brazil. Electronic address: brenosanvicente@gmail.com.

F S Lumertz (FS)

Developmental Cognitive Neuroscience Laboratory, Brain Institute, Pontifical Catholic University of Rio Grande do Sul, Pontifical Catholic University of Rio Grande do Sul, Ipiranga Avenue, 6681, 11, 936. Partenon, 90619-900, Porto Alegre, RS, Brazil. Electronic address: fsindermannlumertz@gmail.com.

G A Salum (GA)

Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos Street, 2350 - Santa Cecilia, Porto Alegre, RS 90035-007, Brazil. Electronic address: gsalumjr@gmail.com.

R Grassi-Oliveira (R)

Developmental Cognitive Neuroscience Laboratory, Brain Institute, Pontifical Catholic University of Rio Grande do Sul, Pontifical Catholic University of Rio Grande do Sul, Ipiranga Avenue, 6681, 11, 936. Partenon, 90619-900, Porto Alegre, RS, Brazil. Electronic address: rodrigo.grassi@pucrs.br.

B B Quednow (BB)

Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Lenggstrasse 31, CH-8032, Zurich, Switzerland; Neuroscience Center Zurich, University of Zurich and Swiss Federal Institute of Technology Zurich, Rämistrasse 101, CH-8092 Zürich, Switzerland. Electronic address: quednow@bli.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH